FRM 6308

Drug Profile

FRM 6308

Alternative Names: EVP-6308; FRM-6308

Latest Information Update: 09 Jan 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator EnVivo Pharmaceuticals
  • Developer FORUM Pharmaceuticals
  • Class Antipsychotics; Mood stabilisers
  • Mechanism of Action Phosphodiesterase 10A inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Schizophrenia

Most Recent Events

  • 01 Jun 2016 Discontinued - Phase-I for Schizophrenia in USA (PO)
  • 26 Apr 2016 Phase I development is ongoing in USA
  • 30 Jun 2014 FORUM Pharmaceuticals completes a phase I trial in Healthy volunteers in USA (NCT02001389)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top